A New Paradigm for Treating to Target with Second-Generation Obesity Medications
Our team will work closely with you to combine semaglutide therapy with personalized nutrition counseling and fitness recommendations, ensuring you achieve your goals safely and effectively
[22] Vilsbll T, et al
Unlike standard sterile water, this formulation retains sterility through multiple uses, making it ideal for frequent laboratory protocols

GLP-1 receptor agonists Primary mechanism(s) of action Increase glucose-dependent insulin secretion, reduce post-prandial glucagon, and delay gastric emptying (resulting in reduced after meal glucose levels and increased satiety) Examples Exenatide (Byetta 10 mcg Pen, Byetta 5 mcg Pen, Bydureon BCise 2 mcg Pen) Dosage Immediate release (Byetta) Initial: 5 mcg subcutaneous injection twice daily a maximum of 60 minutes before morning and evening meals, or before the two main meals of the day Maximum: 10 mcg subcutaneous injection twice daily a maximum of 60 minutes before morning and evening meals, or before the two main meals of the day Extended release (Bydureon BCise) Initial: 2 mg subcutaneous injection once weekly Maximum: 2 mg subcutaneous injection weekly Lixisenatide (Adlyxin) Short-acting Dosage Initial: 10 mcg subcutaneous injection once daily, up to one hour before the first meal of the day, for 14 days
This works especially well with 10 mg vials where concentration is higher